126 related articles for article (PubMed ID: 2416568)
21. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
22. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?
Caspary EA; Field EJ
Br Med J; 1971 Jun; 2(5762):613-7. PubMed ID: 4103278
[TBL] [Abstract][Full Text] [Related]
23. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
Cercek L; Cercek B
Eur J Cancer (1965); 1977 Sep; 13(9):903-15. PubMed ID: 334557
[No Abstract] [Full Text] [Related]
24. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.
Dickinson JP; Caspary EA; Field EJ
Br J Cancer; 1973 Feb; 27(2):99-105. PubMed ID: 4735112
[TBL] [Abstract][Full Text] [Related]
25. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
Wiltschke C; Krainer M; Budinsky AC; Berger A; Müller C; Zeillinger R; Speiser P; Kubista E; Eibl M; Zielinski CC
Br J Cancer; 1995 Jun; 71(6):1292-6. PubMed ID: 7779726
[TBL] [Abstract][Full Text] [Related]
26. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
[TBL] [Abstract][Full Text] [Related]
27. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
Cercek L; Cercek B
Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
[TBL] [Abstract][Full Text] [Related]
28. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
29. Bovine ocular squamous-cell carcinoma: lymphocyte response to phytohaemagglutinin and tumour antigen.
Jennings PA; Lavin MF; Hughes DJ; Spradbrow PB
Br J Cancer; 1979 Oct; 40(4):608-14. PubMed ID: 497111
[TBL] [Abstract][Full Text] [Related]
30. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
Hashimoto Y; Takaku F; Yamanaka T
Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
[No Abstract] [Full Text] [Related]
31. A contribution to immunological tumour diagnostics in urology.
Günther M; Friedrich A; Erdmann T; Jenssen HL; Werner H; Seyfarth M; Köhler H
Int Urol Nephrol; 1978; 10(2):111-5. PubMed ID: 81191
[TBL] [Abstract][Full Text] [Related]
32. [Extension of the rosette test in the estimation of TAA-binding cells in breast cancer and mastopathy patients].
Sauer H; Preusse C; Gläser A; Hädge D; Kraus I; Ambrosius H
Allerg Immunol (Leipz); 1982; 28(3):177-86. PubMed ID: 6183964
[TBL] [Abstract][Full Text] [Related]
33. An analysis of the SCM test in cancer diagnosis.
Atkinson RJ; Lowry WS; Strain P
Cancer; 1983 Jul; 52(1):91-100. PubMed ID: 6342753
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis of malignant processes of the colon and rectum using a new method for the demonstration of sensitized lymphocytes (PAL-test)].
Bauer HW; Richter H; Schottler S; Ax W
Chir Forum Exp Klin Forsch; 1978; (1978):215-9. PubMed ID: 752589
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
[TBL] [Abstract][Full Text] [Related]
36. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
Emmrich F; Ambrosius H
Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
[TBL] [Abstract][Full Text] [Related]
37. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
Flavell DJ; Potter CW
Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
[TBL] [Abstract][Full Text] [Related]
38. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
Nitzschke U; Zwergel T; Lampert F
Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
[TBL] [Abstract][Full Text] [Related]
39. Apparent tumour specificity with the SCM test.
Cercek L; Cercek B
Br J Cancer; 1975 Feb; 31(2):252-3. PubMed ID: 1164473
[No Abstract] [Full Text] [Related]
40. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
Lampert F; Nitzschke U; Zwergel T
Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
